hotjili cc jili fortune gems
While they might not be producing a wealth of offense, the Kings have been penurious defensively of late and will take that stinginess northward to San Jose for a matchup with the Sharks on Monday. They surrendered just one goal in each contest during their three-game homestand and no five-on-five markers, most recently restraining the Seattle Kraken in a 2-1 win. Seattle had won five of its past six games, whereas San Jose has dropped six of its past seven. David Rittich, who has made three straight starts since Darcy Kuemper sustained his second lower-body injury of the young campaign during a loss in Colorado, has posted six one-goal-allowed efforts in 11 starts, with five of those performances being wins. The sixth was a 1-0 loss to Buffalo on Wednesday, which coach Jim Hiller said he thought gave the Kings additional motivation against Seattle. “I think we played really well the last couple (games), but (against Seattle) we did something extra with obviously scoring goals, which gives us the opportunity to win,” Rittich said. Individual Kings had plenty of motivation, too. Their second-period power-play goal represented the first point in seven games for Kevin Fiala and the first goal in six for Quinton Byfield, as well as the first power-play goal by any King against a goalie in the past seven games. Byfield’s scoring woes have been longer-standing. Byfield said he’d like to better integrate the physical side of his game into his offense, but for now was pleased to have broken through, and with an authoritative snipe, no less. “It’s obviously tough. You do think about it, but you’ve got to stay positive. I’ve learned from the best, Kopi, all the time he’s just even keel,” said Byfield, referring to Kings captain Anze Kopitar. “I try to be happy, that’s just my personality. I don’t want to bring anyone else down around me. It always comes eventually, and hopefully it’ll pile up.” Saturday also marked Byfield’s 200th career game, and he joined seven other players who have crossed that threshold from his 2020 draft class. He accumulated those games across parts of five seasons, some of which saw him bounce between the NHL and AHL while he also battled serious injuries and illnesses. “It was tough. There was a lot of adversity and a lot of challenging moments in those 200 games,” Byfield said. There might not be a ton of adversity ahead for the Kings in San Jose, given that the Sharks remain in a half-decade-long rebuild still waiting to take off and have been mired in a funk lately, too. But the Kings managed to lose to them and another bottom-dweller, the Chicago Blackhawks, in the same week, and their 4-2 loss in San Jose on Oct. 29 featured an 0-for-6 display on the power play. Five days earlier, the Kings had beaten the Sharks, 3-2, in L.A. The No. 1 overall pick in the 2024 draft, Macklin Celebrini, did not compete in either meeting for San Jose. He’ll be healthy Monday and has scored seven points in 10 games, production spearheaded by three multi-point outings. Veteran Mikael Granlund’s 24 points are eight more than any other Shark has contributed this season.
A 7-year-old rivalry between tech leaders Elon Musk and Sam Altman over who should run OpenAI and prevent an artificial intelligence "dictatorship" is now heading to a federal judge as Musk seeks to halt the ChatGPT maker's ongoing shift into a for-profit company. Musk, an early OpenAI investor and board member, sued the artificial intelligence company earlier this year alleging it had betrayed its founding aims as a nonprofit research lab benefiting the public good rather than pursuing profits. Musk has since escalated the dispute, adding new claims and asking for a court order that would stop OpenAI’s plans to convert itself into a for-profit business more fully. The world's richest man, whose companies include Tesla, SpaceX and social media platform X, last year started his own rival AI company, xAI. Musk says it faces unfair competition from OpenAI and its close business partner Microsoft, which has supplied the huge computing resources needed to build AI systems such as ChatGPT. “OpenAI and Microsoft together exploiting Musk’s donations so they can build a for-profit monopoly, one now specifically targeting xAI, is just too much,” says Musk's filing that alleges the companies are violating the terms of Musk’s foundational contributions to the charity. OpenAI is filing a response Friday opposing Musk’s requested order, saying it would cripple OpenAI’s business and mission to the advantage of Musk and his own AI company. A hearing is set for January before U.S. District Judge Yvonne Gonzalez Rogers in Oakland. At the heart of the dispute is a 2017 internal power struggle at the fledgling startup that led to Altman becoming OpenAI's CEO. Musk in an email outlined a plan where he would “unequivocally have initial control of the company” but said that would be temporary. He grew frustrated after two other OpenAI co-founders said he would hold too much power as a major shareholder and chief executive if the startup succeeded in its goal to achieve better-than-human AI known as artificial general intelligence , or AGI. Musk has long voiced concerns about how advanced forms of AI could threaten humanity. “The current structure provides you with a path where you end up with unilateral absolute control over the AGI," said a 2017 email to Musk from co-founders Ilya Sutskever and Greg Brockman. “You stated that you don't want to control the final AGI, but during this negotiation, you've shown to us that absolute control is extremely important to you.” In the same email, titled “Honest Thoughts,” Sutskever and Brockman also voiced concerns about Altman's desire to be CEO and whether he was motivated by “political goals.” Altman eventually succeeded in becoming CEO, and has remained so except for a period last year when he was fired and then reinstated days later after the board that ousted him was replaced. OpenAI published the messages Friday in a blog post meant to show its side of the story, particularly Musk's early support for the idea of making OpenAI a for-profit business so it could raise money for the hardware and computer power that AI needs. It was Musk, through his wealth manager Jared Birchall, who first registered “Open Artificial Technologies Technologies, Inc.”, a public benefit corporation, in September 2017. Then came the “Honest Thoughts” email that Musk described as the “final straw.” “Either go do something on your own or continue with OpenAI as a nonprofit,” Musk wrote back. OpenAI said Musk later proposed merging the startup into Tesla before resigning as the co-chair of OpenAI's board in early 2018. Musk didn't immediately respond to emailed requests for comment sent to his companies Friday. Asked about his frayed relationship with Musk at a New York Times conference last week, Altman said he felt “tremendously sad” but also characterized Musk’s legal fight as one about business competition. “He’s a competitor and we’re doing well,” Altman said. He also said at the conference that he is “not that worried” about the Tesla CEO’s influence with President-elect Donald Trump. OpenAI said Friday that Altman plans to make a $1 million personal donation to Trump’s inauguration fund, joining a number of tech companies and executives who are working to improve their relationships with the incoming administration. —————————— The Associated Press and OpenAI have a licensing and technology agreement allowing OpenAI access to part of the AP’s text archives.
TEL AVIV, Israel (AP) — Israeli Prime Minister Benjamin Netanyahu underwent successful surgery Sunday to have his prostate removed, hospital officials said, a procedure that came as he manages multiple crises including the war in Gaza and his trial for alleged corruption . Netanyahu, who has had a series of health issues in recent years, has gone to great lengths to bolster a public image of himself as a healthy, energetic leader. During his trial this month, he boasted about working 18-hour days, accompanied by a cigar. But as Israel's longest-serving leader, such a grueling workload over a total of 17 years in power could take a toll on his well-being. Netanyahu, 75, is among older world leaders including U.S. President Joe Biden, 82 , President-elect Donald Trump, 78 , Brazil's President Luiz Inácio Lula da Silva , 79, and Pope Francis , 88, who have come under scrutiny for their age and health issues. Netanyahu's latest condition is common in older men, but the procedure has had some fallout. The judges overseeing his trial accepted a request from his lawyer on Sunday to call off three days of testimony scheduled this week. The lawyer, Amit Hadad, had argued that Netanyahu would be fully sedated for the procedure and hospitalized for “a number of days.” Jerusalem's Hadassah Medical Center announced late Sunday that the procedure had been completed successfully and that the prime minister had woken up. Netanyahu thanked his doctors. His office said he was "fully alert" and was taken to an underground recovery unit fortified against potential missile attacks. Netanyahu was expected to remain in the hospital for several days of observation. Justice Minister Yariv Levin, a close ally, served as acting prime minister during the operation. With so much at stake, Netanyahu’s health in wartime is a concern for both Israelis and the wider world. As Israel’s leader, Netanyahu is at the center of major global events that are shifting the Middle East . With the dizzying pace of the past 14 months, being incapacitated for even a few hours can be risky. Netanyahu will be in the hospital at a time when international mediators are pushing Israel and Hamas to reach a ceasefire in Gaza and as fighting between Israel and Yemen’s Iran-backed Houthi rebels intensifies . Prostate issues are common and in many cases easily treatable. Still, the procedure puts a dent in Netanyahu’s image of vigor at a time when he would want to project strength more than ever, both to an Israeli audience navigating constant threats as well as to Israel’s enemies looking to expose its weaknesses. Netanyahu insists he is in excellent health. His office releases footage of him touring war zones in full protective gear flanked by military officers, or meeting with defense officials on windswept hilltops in youthful dark shades and puffer jackets. But that image was shattered last year when Netanyahu’s doctors revealed that he had a heart condition , a problem that he had apparently long known about but concealed from the public. A week after a fainting spell, Netanyahu was fitted with a pacemaker to control his heartbeat. Only then did staff at the Sheba Medical Center reveal that Netanyahu has for years experienced a condition that can cause irregular heartbeats. The revelation came as Netanyahu was dealing with massive anti-government protests. The news about a chronic heart problem stoked further anger and distrust during extreme political polarization in Israel. Last year, Netanyahu was rushed to the hospital for what doctors said likely was dehydration . He stayed overnight, prompting his weekly Cabinet meeting to be delayed. Earlier this year, Netanyahu underwent hernia surgery , during which he was under full anesthesia and unconscious. Levin served as acting prime minister during the operation. According to Netanyahu’s office, the Israeli leader was diagnosed with a urinary tract infection on Wednesday stemming from a benign enlargement of his prostate. The infection was treated successfully with antibiotics, but doctors said the surgery was needed in any case. Complications from prostate enlargement are common in men in their 70s and 80s, Dr. Shay Golan, head of the oncology urology service at Israel’s Rabin Medical Center, told Israeli Army Radio. Golan spoke in general terms and was not involved in Netanyahu’s care or treatment. He said an enlarged prostate can block proper emptying of the bladder, leading to a build-up of urine that can lead to an infection or other complications. After medicinal treatment, doctors can recommend a procedure to remove the prostate to prevent future blockages, Golan said. In Netanyahu’s case, because the prostate is not cancerous, Golan said doctors were likely performing an endoscopic surgery, carried out by inserting small instruments into a body cavity, rather than making surgical cuts in the abdomen to reach the prostate. The procedure lasts about an hour, Golan said, and recovery is quick. He said that aside from catheter use for one to three days after the procedure, patients can return to normal activity without significant limitations. AP correspondent Isaac Scharf contributed reporting.Sportscaster Greg Gumbel dies from cancer at age 78
Apple Inc. ( NASDAQ:AAPL – Get Free Report )’s share price fell 1.5% during mid-day trading on Friday . The company traded as low as $254.50 and last traded at $255.03. 9,851,505 shares were traded during mid-day trading, a decline of 83% from the average session volume of 57,154,902 shares. The stock had previously closed at $259.02. Analyst Upgrades and Downgrades Several research analysts have commented on the company. Monness Crespi & Hardt restated a “buy” rating and issued a $245.00 target price on shares of Apple in a research note on Monday, September 9th. New Street Research restated a “neutral” rating and set a $225.00 price objective on shares of Apple in a research report on Wednesday, September 25th. Wedbush upped their target price on shares of Apple from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Thursday. Barclays reduced their target price on Apple from $186.00 to $184.00 and set an “underweight” rating on the stock in a research note on Friday, November 1st. Finally, Citigroup increased their target price on shares of Apple to $185.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, twenty-three have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $237.47. Get Our Latest Analysis on AAPL Apple Stock Performance Apple ( NASDAQ:AAPL – Get Free Report ) last released its quarterly earnings results on Thursday, October 31st. The iPhone maker reported $1.64 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.04. Apple had a return on equity of 152.94% and a net margin of 23.97%. The company had revenue of $94.93 billion during the quarter, compared to analysts’ expectations of $94.52 billion. During the same quarter in the prior year, the firm posted $1.46 EPS. Apple’s quarterly revenue was up 6.1% compared to the same quarter last year. As a group, sell-side analysts expect that Apple Inc. will post 7.43 earnings per share for the current fiscal year. Apple Announces Dividend The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 14th. Shareholders of record on Monday, November 11th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.39%. The ex-dividend date of this dividend was Friday, November 8th. Apple’s payout ratio is 16.45%. Insider Buying and Selling In other Apple news, COO Jeffrey E. Williams sold 100,000 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $249.97, for a total value of $24,997,000.00. Following the transaction, the chief operating officer now owns 389,944 shares in the company, valued at approximately $97,474,301.68. This trade represents a 20.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website . Also, insider Chris Kondo sold 4,130 shares of the stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $228.87, for a total transaction of $945,233.10. Following the completion of the sale, the insider now owns 15,419 shares of the company’s stock, valued at approximately $3,528,946.53. The trade was a 21.13 % decrease in their position. The disclosure for this sale can be found here . Insiders sold a total of 508,170 shares of company stock worth $117,004,745 in the last 90 days. Insiders own 0.06% of the company’s stock. Institutional Investors Weigh In On Apple Several hedge funds and other institutional investors have recently bought and sold shares of AAPL. SMART Wealth LLC boosted its holdings in Apple by 3.6% in the 3rd quarter. SMART Wealth LLC now owns 14,580 shares of the iPhone maker’s stock valued at $3,397,000 after purchasing an additional 507 shares during the last quarter. Legacy Wealth Management LLC MS raised its position in shares of Apple by 7.6% during the 3rd quarter. Legacy Wealth Management LLC MS now owns 73,945 shares of the iPhone maker’s stock valued at $17,229,000 after buying an additional 5,231 shares during the period. SPX Gestao de Recursos Ltda acquired a new position in Apple in the third quarter valued at approximately $71,000. Alternative Investment Advisors LLC. grew its position in Apple by 6.7% in the third quarter. Alternative Investment Advisors LLC. now owns 5,831 shares of the iPhone maker’s stock worth $1,359,000 after acquiring an additional 366 shares during the period. Finally, Birmingham Capital Management Co. Inc. AL increased its stake in Apple by 23.6% during the third quarter. Birmingham Capital Management Co. Inc. AL now owns 24,462 shares of the iPhone maker’s stock worth $5,700,000 after acquiring an additional 4,675 shares during the last quarter. 67.73% of the stock is currently owned by institutional investors and hedge funds. About Apple ( Get Free Report ) Apple Inc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, and HomePod. Recommended Stories Five stocks we like better than Apple Stock Average Calculator Buffett Takes the Bait; Berkshire Buys More Oxy in December Airline Stocks – Top Airline Stocks to Buy Now Top 3 ETFs to Hedge Against Inflation in 2025 Best Aerospace Stocks Investing These 3 Chip Stock Kings Are Still Buys for 2025 Receive News & Ratings for Apple Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apple and related companies with MarketBeat.com's FREE daily email newsletter .
Trump asks the Supreme Court to delay the start of the TikTok ban
At the NeurIPS conference, former OpenAI chief scientist Ilya Sutskever forecasted that the integration of reasoning capabilities in AI would lead to unpredictability in technological outcomes. Sutskever, receiving a 'Test of Time' award, discussed the limitations of current pre-training models. Despite achievements like OpenAI's ChatGPT, he noted that data expansion is reaching a plateau due to the finite nature of the internet. He proposed alternatives, such as AI generating new data or refining answers to enhance accuracy. Sutskever co-founded Safe Superintelligence Inc envisioning superintelligent, self-aware machines that can reason like humans, but warned of their inherent unpredictability. (With inputs from agencies.)Sportscaster Greg Gumbel dies from cancer at age 78